Zobrazeno 1 - 10
of 457
pro vyhledávání: '"W. Wedekind"'
Autor:
Wedekind, W.G.P.E.
Publikováno v:
Bouwrecht : Documentatieblad voor Rechtspraak en Literatuur op het Stuk van Bouwrecht, 9, 746-746
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::ced94073a81b29d6ce3e4f61a375aa33
https://dare.uva.nl/personal/pure/en/publications/de-uitkomsten-van-de-parlementaire-enquete-bouwnijverheid-hoe-nu-verderopeningswoord-door-de-dagvoorzitter-prof-dr-w-wedekind(af5847e7-f77d-4134-9252-1b88bf96df8a).html
https://dare.uva.nl/personal/pure/en/publications/de-uitkomsten-van-de-parlementaire-enquete-bouwnijverheid-hoe-nu-verderopeningswoord-door-de-dagvoorzitter-prof-dr-w-wedekind(af5847e7-f77d-4134-9252-1b88bf96df8a).html
Publikováno v:
Bouwrecht : Documentatieblad voor Rechtspraak en Literatuur op het Stuk van Bouwrecht. 9:746-746
Autor:
David S. Clark
Publikováno v:
International Journal of Legal Information. 17:272-273
Autor:
Ali, Liaqat1 (AUTHOR) liaqatbiotech23@gmail.com, Ahmad, Nisar1 (AUTHOR) ahmadn@uswat.edu.pk, Uddin, Muhammad Nazir1 (AUTHOR) w.khan@uswat.edu.pk, Abdel-Maksoud, Mostafa A.2 (AUTHOR) mabdmaksoud@ksu.edu.sa, Fazal, Hina3 (AUTHOR), Fatima, Sabiha4 (AUTHOR) sabmehdi@ksu.edu.sa, El-Tayeb, Mohamed A.4 (AUTHOR) mali5@ksu.edu.sa, Kiani, Bushra Hafeez5 (AUTHOR) bushra.hafeez@iiu.edu.pk, Khan, Wajid1 (AUTHOR) muradrahat@uswat.edu.pk, Rahat, Murad Ali1 (AUTHOR) alimoh@uswat.edu.pk, Ali, Mohammad1 (AUTHOR) shaazkhan068@gmail.com, Khan, Yaqub1 (AUTHOR) salmanbiotech6168@gmail.com, Rauf, Kamran6 (AUTHOR) raufkamran317@gmail.com, Khan, Salman1 (AUTHOR) samibiotech22@gmail.com, Ullah, Sami1 (AUTHOR) tanveerbiotech88@gmail.com, Ahmad, Tanveer1 (AUTHOR) awaisnaveed085@gmail.com, Salam, Afshan1 (AUTHOR) sajjad.std.mus@gmail.com, Ahmad, Sajjad1 (AUTHOR)
Publikováno v:
Pharmaceuticals (14248247). Nov2024, Vol. 17 Issue 11, p1546. 24p.
Autor:
W. Wedekind, W. Dimpfel
Publikováno v:
Clinical Neurophysiology. 127:e39-e40
A patient (born in 1943) with generalized anxiety since 2008 developed Parkinsonian tremor in 2010. First quantitative EEG recording (neo-CATEEM software using 10/20 electrode positions) was obtained on 10.02.2011. Comparison of spectral power to a n
Publikováno v:
Neuropsychobiology. 35:132-142
The aim of this randomized, double-blind, placebo-controlled 16-week study was to investigate the clinical efficacy of cyclandelate (Natil, 1,600 mg/day) in 139 adult outpatients with cognitive impairment (70 allocated to cyclandelate; 69 to placebo)
Publikováno v:
Zeitschrift für Phytotherapie. 34
Autor:
Hans-Christoph Diener, M Föh, Peter Wessely, C Iaccarino, H Strenge, Hansruedi Isler, Z Taneri, M Fischer, W Wedekind
Publikováno v:
Cephalalgia. 16:441-447
Cyclandelate inhibits calcium-induced contraction of vascular smooth muscle cells, platelet aggregation induced by thrombin, platelet-activating-factor and adenosine, and also suppresses a provoked 5HT release from platelets. This pharmacological pro
Publikováno v:
Klinische Wochenschrift. 69:313-319
The effect of cyclandelate (Natil®) on the CNS was tested in a double-blind, placebocontrolled pilot study on 48 healthy males using a single oral dosage of 1200 mg. The EEG was evaluated quantitatively by spectral analysis before and one hour as we
Publikováno v:
European journal of medical research. 8(5)
The psychophysiological model of provoking different emotional states by watching film excerpts with various emotional contents was used to characterize drug action in 80 subjects (male/female=50%) with threshold emotional disturbance within a random